Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches.

Published on IRCCS materno infantile Burlo Garofolo (https://www.burlo.trieste.it)

Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. [1]

Titolo	Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches.
Publication Type	Journal Article
Authors	De Leo, L [2], Marcuzzi, A [3], Decorti, G [4], Tommasini, A [5], Crovella, S [6], Pontillo, A [7]
PubMed ID	20206266 [8]

Source URL: https://www.burlo.trieste.it/ricerca/pubblicazioni/targeting-farnesyl-transferase-novel-therapeutic-strategy-mevalonate-kinase-deficiency-vitro-and-vivo#comment-0

Collegamenti
[1] https://www.burlo.trieste.it/ricerca/pubblicazioni/targeting-farnesyl-transferase-novel-therapeutic-strategy-mevalonate-kinase-deficiency-vitro-and-vivo
[2] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=46
[3] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=36
[4] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=356
[5] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=89
[6] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=38
[7] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=39
[8] http://www.ncbi.nlm.nih.gov/pubmed/20206266?dopt=Abstract